Упрощенная HTML-версия
106.Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin
E2 synthesis in MKN 28 gastric mucosal cells in vitro / M. Romano, V. Ricci, A. Memoli et al. // J.
Biol. Chem. – 1998. – Vol. 273. – P. 28560–28563.
107.Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related
gastroduodenal ulcer complications / J.L. Goldstein, K.B. Howard, S.M. Walton et al. // Clin.
Gastroenterol. Hepatol. – 2006. – Vol. 4, №11. – Р. 1337-1345.
108.Importance of age and other risk factors in NSAID-induced gastropathy / H.L. Lee, D.S.
Han, J.B. Kim et al. // Korean J. Gastroenterol. – 2004. – Vol. 44,№5. – Р. 246-251.
109.Indometacin up-regulates TFF2 expression in gastric epithelial cells / A. Koitabashi, T.
Shimada, Y. Fujii et al. // Aliment. Pharmacol. Ther. – 2004. – Vol. 20, Suppl 1. – P. 171-176.
110.Infection of Helicobacter pylori in gastric adaptation to continued administration of
aspirin in humans / J.W. Konturek, A. Dembinski, S.J. Konturek et al. // Gastroenterology. – 1998. –
Vol.114. – P. 245–255.
111.Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori
and NSAID / C.Y. Wu, M.S. Wu, Y.J. Chen et al. // Hepatogastroenterology. – 2006. – Vol. 53,
№71. – Р. 797-803.
112.Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into
mechanisms and implications for cancer growth and ulcer healing / Jones M.K., Wang H., Peskar
B.M. et al. // Nat. Med.- 1999. - №5. – P. 1418–1423.
113.Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-
inflammatory nonsteroidal drugs / S. Fiorucci, E. Antonelli, E. Distrutti et al. // Gastroenterology. –
2005. – Vol. 129,№4. – Р. 1210-1224.
114.Interaction of Helicobacter polyri and indomethacin in gastric mucosa injury of Balb/c
mice / K.Y. Ji, F.J. Hu, A.D. Li et al. // Zhonghua. Yi. Xue. Za. Zhi. – 2003. – Vol. 83,№9. – Р. 726-
730.
115.Ji K.Y. Interaction or relationship between Helicobacter pylori and non-steroidal anti-
inflammatory drugs in upper gastrointestinal diseases / K.Y. Ji, F.L. Hu // World. J. Gastroenterol. –
2006. –Vol. 12, №24. – Р. 3789-3792.
116.Kessler W.F. Surgical complications of nonsteroidal antiinflammatory drug-induced
small bowel ulceration / W.F. Kessler, G.T. Shires 3rd, T.J. Fahey 3rd // J. Am. Coll. Surg. – 1997.
Vol. 185, № 3. – Р. 250-254.
117.Kullmann F. Effect of ursodeoxycholic acid on the inflammatory activity of
indomethacin-induced intestinal inflammation in rats / F. Kullmann, V. Gross, J. Ruschoff et al. // Z.
Gastroenterol. – 1997. Vol. 35, № 3. – Р. 171-178.
118.Kwo P.Y. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion
and review of the literature / P.Y. Kwo, W.J. Tremaine // Mayo. Clin. Proc. – 1995. Vol. 70, № 1. –
Р. 55-61.
119.Ladwa M. Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori
/ M. Ladwa, K. Takeuchi, I. Bjarnason // Scand. J. Gastroenterol. – 2006. – Vol. 41, №4. – Р. 373-
375.
120.Lanas A. Inappropriate Prevention of NSAID-Induced Gastrointestinal Events Among
Long-Term Users in the Elderly / A. Lanas, A. Ferrandez // Drugs. Aging. – 2007. – Vol. 24, №2. –
Р. 121-131.
121.Lanas A. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? /
A. Lanas, C. Scarpignato // Digestion. 2006. Vol. 73, Suppl 1.- P. 136-150.
122.Lewis J.H. Drug- and chemical-induced cholestasis / J.H. Lewis, H.J. Zimmerman //
Clin. Liver. Dis. – 1999. Vol. 3, № 3. – Р. 433-464.